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ABSTRACT
The majority of HIV-infected patients develop Candida spp-associated clinical oral 
lesions. Studies have shown that asymptomatic oral colonization of Candida spp may lead to 
oral lesions or become a source of disseminated infections. The aim of this study was to verify 
the effects of periodontal conditions on Candida spp prevalence and Candida spp carriage 
in the oral cavity of HIV-infected patients compared to non-infected patients. Twenty-five 
patients not infected with HIV and 48 HIV-infected patients were classified according to 
periodontal conditions as being periodontal healthy or with periodontal disease. Candida 
spp carriage and classification were performed in oral rinse samples. Viral load and CD4+ T 
lymphocyte (CD4+L) counts were performed in blood samples from HIV-infected patients. 
No differences in Candida spp prevalence related to HIV status or periodontal condition 
were detected. However, Candida spp carriage was increased in periodontally affected HIV-
infected patients when compared to periodontally healthy HIV-infected patients (p= 0.04). 
Periodontally healthy HIV-infected patients presented Candida spp carriage in similar levels 
as healthy or periodontally affected non-HIV-infected patients. Candida spp carriage was 
correlated with CD4+L counting in HIV-infected patients. We concluded that periodontal 
disease is associated with increased Candida spp carriage in HIV-infected patients and may 
be a predisposing factor to clinical manifestations of candidiasis.
KEYWORDS: HIV infection. Oral Candida carriage. Periodontal disease. Candida spp. 
INTRODUCTION
In the last few decades, an increase in the prevalence of fungal oral infections 
was observed and they seem to be related to the growing antibiotic use and the 
immunosuppressive condition, especially in AIDS patients1. Most of the infections 
are related to Candida spp, which is generally a commensal in the oral cavity, but in 
immunologically-compromised patients it can assume pathogenic characteristics2. 
Some studies showed that candidiasis comes from commensal strains and that 
asymptomatic oral colonization can lead to oral lesions or become a source of 
disseminated infections3-5.
C. albicans is the most common species isolated in oral candidiasis6; however, 
other species, such as C. tropicalis, C. glabrata, C. parapsilosis, C. stellatoidea, 
C. guilliermondii, and C. krusei were also observed7.
In healthy individuals, the prevalence of Candida spp in the oral cavity is 
40-60%8 while in HIV-infected patients, the prevalence increases to 62-93%9,10. 
Oral candidiasis is the most common lesion associated with HIV infection. It is 
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considered one of the first clinical signs of HIV-related 
immunosuppression and it is highly predictable of the 
disease evolution11. Studies have shown that the prevalence 
of oral candidiasis varies between 20% and 70% in HIV-
infected patients6,11, and although a decline in its prevalence 
has been observed after the antiretroviral therapy (ART) 
era12, it is estimated that 90% of HIV-infected patients 
will develop oral candidiasis during the evolution of HIV 
infection13, emphasizing the importance of studies on this 
topic. Among the factors that predispose to oral candidiasis 
are smoking14, age3,15 and oral hygiene16. According to 
many studies, the presence of yeasts in the biofilm, mainly 
C. albicans, contribute not only to oral candidiasis, but to 
dental caries16,17 and periodontal disease18-20.
Studies on the correlation between Candida spp and 
the etiology and aggravation of periodontal diseases are 
important, but it is also essential to verify the effects of 
periodontal conditions on Candida spp carriage, either 
due to the possible correlation with the development of 
oral lesions or systemic disseminations3-5. Thus, due to 
the importance and prevalence of Candida spp associated 
with oral diseases in HIV-infected patients, the aim of 
this study was to identify different species of Candida 
in oral rinses from patients with and without periodontal 
disease in two population groups, with and without HIV 
infection. Furthermore, to quantify the number of Candida 
ssp colonies in the oral rinses between not infected and 
HIV-infected patients with and without periodontal disease.
MATERIALS AND METHODS
The study protocol was approved by the Ethics 
Committee of the Clinical Hospital of the School of 
Medicine of Ribeirão Preto, University of São Paulo, 
Ribeirão Preto (protocol Nº 3621/2011). The procedures 
were performed in accordance with the ethical standards 
on human experimentation and the Helsinki Declaration 
of 1975 and 1983 revision. Prior to selection, oral and 
written explanations about the research protocol were given 
to eligible participants. All patients provided a written 
informed consent before their participation in this study.
Twenty-five patients not infected with HIV and 48 HIV-
infected patients were selected from the Clinical Hospital 
of the School of Medicine of Ribeirão Preto, University of 
São Paulo. Patients were over 18 years old, had more than 
19 teeth, and had not received any periodontal treatment, 
antibiotic therapy, anti-inflammatory or antifungal therapy 
in the three months before the study participation. 
All patients had no clinical signs of candidiasis and 
no history of complete or partial removable prosthesis use 
with palatal coverage. Participants with other oral lesions 
associated with HIV were not excluded from the study. 
Only patients who met the following criteria were selected: 
no clinical sign of periodontal disease, no probing depth 
greater than 4 mm, no loss of attachment and less than 20% 
of sites with bleeding. Patients who presented more than 
20% of sites with bleeding and/ or at least 4 sites with loss 
of clinical attachment and more than 3 mm and/or 4 sites 
with probing depths than 4 mm were also included.
HIV-infected patients presented HIV seropositivity 
confirmed by ELISA and Western Blot tests, as well as 
by a recent viral load and CD-4+ T lymphocyte (CD4+L) 
count exams (at least three months before the beginning 
of the study).
Patients’ Clinical Evaluation
Patients underwent examination and collection of an oral 
rinse sample. The periodontal exam was performed after 
the collection of the oral rinse sample, so bleeding could 
not possibly interfere with the quality of collected samples. 
For the periodontal exam, we used a millimeter periodontal 
probe and all teeth (except third molars) were probed at 
six sites: mesiobuccal, buccal, distobuccal, mesiolingual, 
lingual and distolingual. In each site, we performed three 
different measures: deep probing, loss of attachment and 
bleeding. 
Related to the periodontal condition, patients were 
classified into periodontally healthy or with periodontal 
disease. The periodontally healthy were patients who had 
no clinical sign of periodontal disease, no probing depth 
greater than 4 mm, no loss of attachment and less than 20% 
of sites with bleeding. The patients who were periodontally 
affected presented more than 20% of sites with bleeding 
and/ or at least 4 sites with loss of clinical attachment and 
more than 3 mm and/ or 4 sites with probing depths than 
4 mm21.
Biological Sample Collection
Oral Rinse Sample
One day before collection, sterilized bottles with 10 ml 
of PBS were prepared in autoclaves (pH 7.3, 0.1 M) and 
conditioned at 4 °C until use. Before oral rinse collection, 
the subjects were instructed not to eat, drink, smoke or 
brush their teeth for one hour prior to sample collection 
to minimize the risk of contamination. Participants were 
instructed to rinse with 10 ml of PBS for 60 seconds and 
spit inside a universal collector that was immediately 
centrifuged (2,000 g per 10 minutes). After centrifugation, 
supernatant was discarded and solid residue was diluted in 
1 ml of PBS. In the obtained solution, Candida spp was 
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counted and identified. The count and identification of 
Candida spp were performed in the oral PBS rinse sample 
by the Samaranayke’s technique, described in 198622.
Blood Collection
For blood exams, 10 mL of blood were collected in 
vacuteiner tubes with ethylenediamine tetra-acetic acid 
(EDTA). Plasma was obtained by centrifugation of total 
blood (800 x g per 10 min.), divided in tubes and stored at 
–80 ºC in a maximum period of six months, until its use. 
Laboratorial Analysis 
Viral load and CD4+L count
The HIV-Monitor kit (Roche Diagnostic Systems, 
Branchburg, NJ, USA) was used to quantify the HIV RNA 
(viral load) in -blood plasma. The RNA was extracted from 
the samples using a modified silica protocol (QIAmp RNA 
viral kit; Qiagen, Chatsworth, CA, USA), and polymerase 
chain reaction was performed using the HIV-Monitor kit 
(Roche Diagnostic Systems, Branchburg, NJ, USA). The 
CD4+L counts in the blood plasma were determined by 
flow cytometry (FACS), which was performed within three 
months after sample collection.
Candida spp quantification
The oral rinse samples were diluted in PBS to obtain 
three different concentrations: pure sample, 10x PBS-
diluted sample and 100x PBS-diluted sample. One 
hundred microliters of each concentration was plated in 
duplicate on petri dishes with Agar Sabouraud-Dextrose 
and chloramphenicol and incubated at 37 ºC for 48 hours. 
The colony forming units per milliliter (CFU/ ml) was 
obtained by the mean between duplicates of positive 
culture. Depending on the number of CFU/ mL, counts 
were categorized into 0 (none), 1 (isolated, <10 CFU/mL), 
2 (moderate, 10-102 CFU/ mL), 3 (many, 102-103 CFU/mL) 
and 4 (massive, >103 CFU/ mL)23.
Candida spp identification
To identify Candida spp, 100 microliters of oral 
rinse 10x PBS-diluted were plated on petri dishes with 
CHROMagar Candida. Later, colonies were plated in 
tubes with Sabouraud Dextrose Agar (Himedia, India) and 
incubated at 37 °C per 24 hours. From such inocula in the 
exponential growth state, the following were performed: 
fungal microcultivated test24, germ tube formation25; 
hypertonic Sabouraud broth26; reduction of trifeniltetrazole 
chloride; zimogram; API (ID 32 C); formation of 
germinate tube, chlamydoconidia production, carbohydrates 
fermentation and assimilation24. The species identification 
was obtained based on the positivity or negativity of 
Sandven (1990) tests27. 
Statistical Analyses
Statistical analysis was performed using the Graph 
Pad Prism software (San Diego, CA, USA). Data were 
not normally distributed. Fisher‘s exact test and the 
Chi-squared test were used to compare the number of 
patients using ART, the number of patients who smoked 
and the prevalence of different Candida species in the 
groups. Differences between groups were assessed using 
Chi-squared test. The Mann-Whitney U test was used 
to compare two means, and the one-way Kruskal Wallis 
test was used to compare three or more means. Data are 
presented as the mean ± standard deviation, and for the 
analysis, a confidence interval of 95% was used, and p 
values were considered to be significant when they were 
equal to or less than 0.05.
RESULTS
Seventy-three patients participated in this study: 25 
who were not HIV-infected and 48 who were HIV-infected. 
Patients were divided into four groups according to serum 
status and periodontal condition. Group A: 12 not HIV-
infected and periodontally healthy patients; Group B: 13 not 
HIV-infected and periodontally affected patients; Group C: 
19 HIV-infected and periodontally healthy patients; Group D: 
29 HIV-infected and periodontally affected patients.
The participants of all groups were homogeneous 
-regarding epidemiologic and clinical characteristics, as 
described in Table 1.
Oral Candida spp counting and identification related 
to HIV-infected and non-infected patients’ periodontal 
conditions
In general, we identified oral Candida spp to have an 
equivalent distribution in all groups, as described in Table 2. 
C. albicans and C. parapisilosis were identified in all 
studied groups. C. tropicalis was identified in the C and D 
groups and C. dubliniensis, and C. glabrata, in the D group 
exclusively. Although a major Candida spp variety had been 
verified in the D group, its prevalence was not statistically 
significant (Table 2). 
Candida spp were distributed in a homogeneous way 
among groups, but despite this, Candida spp counting was 
increased in - patients from the D group. Among non-HIV-
infected patients, Candida spp counting did not correlate 
with the periodontal state. In the group A, analysis of the 
oral rinse revealed that 58.3% (n=7) of the samples were 
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Candida carriers, 41.6% (n=5) of the patients showed 
isolated to moderate numbers of CFU/ mL, whereas 16.6% 
(n=2) presented many to massive CFU/ mL. Similar results 
were found in group B: 63.5% (n=8) of the samples were 
Candida carriers; 48.1% (n=6) of the patients showed 
isolated to moderate numbers of CFU/ mL, whereas 15.4% 
(n=2) presented many to massive CFU/ mL (p= 0.97), as 
described in Figure 1A. Differently, among HIV-infected 
patients, group C presented 36.8% (n=7) of the samples 
with isolated to moderate numbers of CFU/ mL and 21.1% 
(n=4) showed many to massive CFU/ mL. High CFU/ mL 
was noted in the group D, 27.6% (n=8) and 55.2% (n=16) 
showed isolated to moderate, and many to massive numbers 
of CFU/ mL, respectively (p= 0.04), as described in 
Figure 1B.
It is important to note that Candida spp counting was 
similar between non-HIV-infected and infected patients 
who were periodontally healthy, groups A and C (p=0.94).
Influence of viral load and CD4+L count on the 
Candida spp carriage of HIV-infected patients
Among HIV-infected patients, we verified that Candida 
spp carriage was associated with viral load and CD4+L 
count. The 11 patients who presented less than 200 cells/mm3 
CD4+L presented 9% (n=1) with none CFU count; 9% 
(n=1) and 82% (n=9) showed isolated to moderate and many 
to massive numbers of CFU, respectively. The 20 patients 
who presented between 200 and 500 CD4+L/mm3 presented 
30% (n=6) with none CFU count, 30% presented isolated to 
Table 1 - Demographic Data and Clinical Parameters of Subjects Stratified by HIV Status and Oral Condition
Group 
A B C D P value
HIV status Negative Negative Positive Positive -
Oral conditions Healthy Gingivitis/Periodontitis Healthy Gingivitis/Periodontitis -
Number of subjects 12 13 19 29 -
Mean age (years) 35 (± 9) 37 (±9) 38 (±9) 39 (±5) 0.411a
Males (%) 50 54 32 55 0.4157b
Smokers (%) 8 23 15 34 0.2473b
Mean number of teeth 27 (±4) 27 (±5) 27 (±5) 26 (±5) 0.6106a
Sites with BOP (%) 9 (±7) 35 (±21) 5 (±6) 30 (±13) <0.0001a
Sites with PPD> 4 mm (%) 0 1,2 (±2) 0 1,3 (±2) <0.0001a
Use of ART (%) 84 79 1.000c
Mean CD-4+ cells 514 (±312) 387 (±276) 0.2254d
Median viral load (cop/ml) <50 <50 0.2365d
aKruskal Wallis test; bChi-squared test; cFisher’s exact test; dMann Whitney test. Group A: Not HIV-infected and periodontally healthy 
patients. Group B: Not HIV-infected and periodontally affected patients. Group C: HIV-infected and periodontally healthy patients. 
Group D: HIV-infected and periodontally affected patients. BOP: bleeding on probing. PPD: probing pocket depth. ART: Antiretro-
viral therapy.
Table 2 - Identification of the Oral Candida spp in Studied Groups
Group A Group B p valuea Group C Group D p valuea
Candida spp 8 (67%) 10 (77%) 0.6728 11 (58%) 24 (83%) 0.0959
Candida albicans 7 (58%) 8 (61%) 1.000 11 (58%) 23 (79%) 0.1931
Candida krusei 0 (0%) 0 (0%) - 0 (0%) 2 (7%) 0.5115
Candida parapisilosis 3 (25%) 2 (15%) 0.6447 1 (5%) 2 (7%) 1.000
Candida tropicalis 0 (0%) 0 (0%) - 1 (5%) 2 (7%) 1.000
Candida dubliniensis 0 (0%) 0 (0%) - 0 (0%) 1 (3%) 1.000
Candida glabrata 0 (0%) 0 (0%) - 0 (0%) 3 (10%) 0.2673
aFisher’s exact test. Group A: Not HIV-infected and periodontally healthy patients. Group B: Not HIV-infected and periodontally af-
fected patients. Group C: HIV-infected and periodontally healthy patients. Group D: HIV-infected and periodontally affected patients
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moderate CFU count and 40% (n=8) showed many to massive 
CFU count. Candida spp carriage was reduced in the 17 
patients with more than 500 CD4+T/ mm3, when compared 
to the patients who presented less than 200 cells/mm3, 
35.3% (n=6) presented none CFU count, 47% (n=8) and 
17.7% (n=3) showed isolated to moderate and many to 
massive numbers of CFU, respectively (p= 0,003), as 
demonstrated in Figure 2A. 
No association between viral load and Candida spp 
carriage was detected. Thirty-three patients with viral load 
less than 100 copies/mL presented 27% (n=9) no CFU count, 
36.5% (n=12) with isolated to moderate and 36.5% with 
many to massive CFU/ mL commensal Candida spp, while 
15 patients presented a viral load greater than 100 copies/mL 
showed 26.7% (n=4) of the participants with none 
CFU/mL count, 20% (n=3) and 53.3% (n=8) with isolated 
to moderate and many to massive numbers of CFU/mL, 
respectively (p=0.45), as demonstrated in Figure 2B. 
DISCUSSION
The majority of HIV-infected patients develops Candida 
spp-associated clinical lesions. These lesions can increase 
in frequency and severity according to the progression 
of HIV infection11. Although the clinical manifestations 
of candidiasis depend on mucosal fungus adhesion and 
colonization28, the asymptomatic Candida spp in HIV-
infected patients with low CD4+L count is also associated 
with clinical disease29. This is the reason why it is of great 
importance to know the predisposing factors of increased 
prevalence of commensal Candida spp in the oral cavity, 
especially HIV-positive patients. 
In this study, we found similar prevalences of different 
commensal Candida species in the oral rinse from non-
HIV-infected and infected patients, regardless of their 
periodontal state. 
The prevalence found in our study was higher than that 
in other studies. Kamtane et al.30, in 2003, verified salivary 
Candida spp in 15% of non-HIV-infected patients and 55% 
in HIV-infected patients. Other studies reported fungus 
colonization in HIV-positive patients between 44% and 
62%9,31-33. In the present study, we verified the presence of 
different Candida spp in 72% of non-HIV-infected patients 
and 73% of HIV-infected patients. The variation among the 
different studies may be due the collection methodology, 
such as the use of swabs, total saliva collection and oral rinse. 
According to Samaranayake et al.22, oral rinse is the most 
sensitive technique for quantifying and detecting Candida 
spp, as used in the present study. No differences in Candida 
spp prevalences were detected in these study groups.
Candida spp carriage was increased in patients with less 
than 200 CD4+L cells when compared to patients presenting 
Figure 2 - (A) Relative Candida spp carriage in HIV-infected 
patients with different CD4+T cells count (< 200, 200-500 and 
> 500 cells/ mm3). A significant difference was found between 
patients with less than 200 CD4+T cells/ mm3 and patients 
with more than 500 CD4+ T cells/ mm3; p= 0.003, Chi-squared 
test; (B) Relative Candida spp carriage in HIV-infected patients 
with different viral loads (< 100 and > 100 copies/ mL); p=0.45, 
Chi-squared test.
Figure 1 - (A) Relative Candida spp carriage in oral rinses of 
non-HIV-infected patients without (Group A) and with (Group B) 
periodontal diseases; p = 0.97, Chi-squared test; (B) Relative 
Candida spp carriage in HIV-infected patients without (Group 
C) and with (Group D) periodontal diseases; p = 0.04, Chi-
squared test.
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more than 500 cells/ mm3 (p= 0.003). These results agree 
with previous studies that verified more colonization in 
inferior CD4+L counting, 200 cells/ mm3 33-35. On the other 
hand, some studies have not found this association32-36. 
The highlight of our work is the high commensal 
Candida spp count in HIV-infected and periodontally 
affected patients, when compared to HIV-infected patients 
not affected by periodontal disease. These results address 
the importance of oral health in oral candidiasis prevention 
because Candida spp density is associated with a higher 
risk for candidiasis development29. On the other hand, 
periodontal conditions were not observed as an important 
factor for Candida spp carriage in non-HIV-infected 
patients. Non-HIV-infected patients presented similar 
Candida spp prevalence and counting, regardless of the 
periodontal state, and these results agree with those of 
Darwazeh et al.37, who verified a similar prevalence and 
counting in 149 orally healthy patients. One limitation of 
this study was the absence of the sample size calculation, 
therefore, the study may not have enough power to detect 
the difference between groups.
Among HIV-infected patients, the periodontal state 
did not influence Candida spp presence or absence, but it 
was responsible for the 4.8 fold increase in counting. This 
increase is epidemiologically important as demonstrated 
by Fong et al.29, in 1997, who showed that candidiasis 
only developed in patients with persistent asymptomatic 
carriage of C. albicans.
The predisposal of HIV-infected patients to more oral 
C. albicans carriage, associated with the influence of oral 
hygiene on Candida spp carriage, are responsible for the 
high values of Candida spp in HIV-infected patients who 
have periodontal disease, as shown in this present study. 
It is important to emphasize that HIV-infected patients 
who presented good periodontal conditions had Candida 
spp levels similar to those of non-HIV-infected patients, 
renforcing the affirmation that the periodontal condition 
may be considered a factor -of increases in the count of 
Candida spp in HIV-infected patients. 
Many studies have shown C. albicans to be an etiologic 
and worsening factor of periodontal disease19,20,38. This study 
shows that periodontal disease increases with Candida spp 
carriage, acting as a vicious cycle in HIV-infected patients 
because in this condition, periodontal disease increases 
Candida spp counts, which worsen periodontal conditions.
In conclusion, periodontal disease may be a factor 
responsible for the increase in commensal Candida spp 
count in HIV-infected patients, and based on current medical 
literature, it is reasonable to affirm that this increase may 
predispose the patient to the development of the clinical 
manifestations of candidiasis. 
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